Td Asset Management Inc Ascendis Pharma A/S Transaction History

Td Asset Management Inc

  • $106 Billion
  • Q4 2024

A detailed history of Td Asset Management Inc transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Td Asset Management Inc holds 339,652 shares of ASND stock, worth $51.7 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
339,652
Previous 253,124 34.18%
Holding current value
$51.7 Million
Previous $37.8 Million 23.7%
% of portfolio
0.04%
Previous 0.04%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
BUY
$122.0 - $146.6 $10.6 Million - $12.7 Million
86,528 Added 34.18%
339,652 $46.8 Million
Q3 2024

Nov 01, 2024
BUY
$113.0 - $153.43 $17.3 Million - $23.5 Million
153,178 Added 153.26%
253,124 $37.8 Million
Q2 2024

Aug 02, 2024
SELL
$121.07 - $153.67 $16.6 Million - $21 Million
-136,924 Reduced 57.81%
99,946 $13.6 Million
Q1 2024

May 08, 2024
SELL
$123.45 - $159.4 $951,552 - $1.23 Million
-7,708 Reduced 3.15%
236,870 $35.8 Million
Q4 2023

Feb 12, 2024
SELL
$86.1 - $127.36 $1.96 Million - $2.9 Million
-22,782 Reduced 8.52%
244,578 $30.8 Million
Q3 2023

Oct 27, 2023
BUY
$86.5 - $103.97 $1.09 Million - $1.31 Million
12,605 Added 4.95%
267,360 $25 Million
Q2 2023

Aug 09, 2023
BUY
$69.96 - $97.84 $1.3 Million - $1.82 Million
18,561 Added 7.86%
254,755 $22.7 Million
Q1 2023

May 10, 2023
BUY
$104.9 - $126.78 $4.18 Million - $5.06 Million
39,894 Added 20.32%
236,194 $25.3 Million
Q4 2022

Feb 06, 2023
BUY
$99.42 - $131.97 $6.43 Million - $8.54 Million
64,700 Added 49.16%
196,300 $24 Million
Q3 2022

Nov 07, 2022
BUY
$84.03 - $110.23 $2.07 Million - $2.71 Million
24,629 Added 23.02%
131,600 $13.5 Million
Q2 2022

Aug 04, 2022
SELL
$78.08 - $117.61 $532,505 - $802,100
-6,820 Reduced 5.99%
106,971 $9.94 Million
Q1 2022

May 10, 2022
BUY
$102.18 - $135.75 $225,613 - $299,736
2,208 Added 1.98%
113,791 $13.4 Million
Q4 2021

Feb 10, 2022
BUY
$127.1 - $169.66 $2.66 Million - $3.55 Million
20,948 Added 23.11%
111,583 $15 Million
Q3 2021

Nov 09, 2021
BUY
$112.67 - $176.92 $1.56 Million - $2.44 Million
13,814 Added 17.98%
90,635 $14.4 Million
Q2 2021

Aug 11, 2021
SELL
$121.62 - $145.29 $3.43 Million - $4.09 Million
-28,174 Reduced 26.83%
76,821 $9.08 Million
Q1 2021

May 14, 2021
SELL
$124.92 - $173.33 $2.72 Million - $3.78 Million
-21,786 Reduced 17.18%
104,995 $13.5 Million
Q4 2020

Feb 16, 2021
BUY
$151.2 - $182.76 $1.67 Million - $2.01 Million
11,016 Added 9.52%
126,781 $21.1 Million
Q3 2020

Nov 10, 2020
SELL
$134.29 - $154.32 $461,957 - $530,860
-3,440 Reduced 2.89%
115,765 $17.9 Million
Q2 2020

Aug 13, 2020
BUY
$110.87 - $156.01 $532,286 - $749,004
4,801 Added 4.2%
119,205 $17.6 Million
Q1 2020

May 15, 2020
SELL
$97.01 - $145.11 $756,678 - $1.13 Million
-7,800 Reduced 6.38%
114,404 $12.9 Million
Q4 2019

Feb 11, 2020
SELL
$91.45 - $139.12 $457,250 - $695,600
-5,000 Reduced 3.93%
122,204 $17 Million
Q3 2019

Nov 07, 2019
BUY
$95.8 - $118.9 $1.23 Million - $1.53 Million
12,836 Added 11.22%
127,204 $12.3 Million
Q2 2019

Aug 01, 2019
BUY
$107.11 - $132.09 $2.89 Million - $3.57 Million
27,000 Added 30.9%
114,368 $13.2 Million
Q1 2019

May 08, 2019
BUY
$62.15 - $129.99 $664,756 - $1.39 Million
10,696 Added 13.95%
87,368 $10.3 Million
Q4 2018

Feb 01, 2019
BUY
$55.16 - $69.67 $575,649 - $727,076
10,436 Added 15.76%
76,672 $4.8 Million
Q3 2018

Nov 01, 2018
BUY
$63.77 - $76.28 $497,406 - $594,984
7,800 Added 13.35%
66,236 $4.69 Million
Q2 2018

Jul 31, 2018
BUY
$58.55 - $73.92 $368,865 - $465,696
6,300 Added 12.08%
58,436 $3.89 Million
Q1 2018

May 11, 2018
BUY
$38.98 - $68.04 $1.28 Million - $2.23 Million
32,836 Added 170.13%
52,136 $3.41 Million
Q4 2017

Feb 02, 2018
BUY
$31.98 - $40.38 $617,214 - $779,334
19,300
19,300 $773,000

Others Institutions Holding ASND

# of Institutions
236
Shares Held
60.2M
Call Options Held
80.3K
Put Options Held
216K
View Full List

About Ascendis Pharma A/S

ASND Quotes by TradingView
  • Ticker ASND
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,810,200
  • Market Cap $8.5B
  • Description
  • Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...
More about ASND
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email